184 related articles for article (PubMed ID: 32986851)
1. Oxysterols in cancer management: From therapy to biomarkers.
Kloudova-Spalenkova A; Holy P; Soucek P
Br J Pharmacol; 2021 Aug; 178(16):3235-3247. PubMed ID: 32986851
[TBL] [Abstract][Full Text] [Related]
2. Oxysterols and retinal degeneration.
Zhang X; Alhasani RH; Zhou X; Reilly J; Zeng Z; Strang N; Shu X
Br J Pharmacol; 2021 Aug; 178(16):3205-3219. PubMed ID: 33501641
[TBL] [Abstract][Full Text] [Related]
3. Oxysterols: From physiological tuners to pharmacological opportunities.
Brown AJ; Sharpe LJ; Rogers MJ
Br J Pharmacol; 2021 Aug; 178(16):3089-3103. PubMed ID: 32335907
[TBL] [Abstract][Full Text] [Related]
4. Cholesterol and oxysterol sulfates: Pathophysiological roles and analytical challenges.
Sanchez LD; Pontini L; Marinozzi M; Sanchez-Aranguren LC; Reis A; Dias IHK
Br J Pharmacol; 2021 Aug; 178(16):3327-3341. PubMed ID: 32762060
[TBL] [Abstract][Full Text] [Related]
5. The oxysterome and its receptors as pharmacological targets in inflammatory diseases.
Guillemot-Legris O; Muccioli GG
Br J Pharmacol; 2022 Nov; 179(21):4917-4940. PubMed ID: 33817775
[TBL] [Abstract][Full Text] [Related]
6. Oxiapoptophagy: A type of cell death induced by some oxysterols.
Nury T; Zarrouk A; Yammine A; Mackrill JJ; Vejux A; Lizard G
Br J Pharmacol; 2021 Aug; 178(16):3115-3123. PubMed ID: 32579703
[TBL] [Abstract][Full Text] [Related]
7. Neuro-oxysterols and neuro-sterols as ligands to nuclear receptors, GPCRs, ligand-gated ion channels and other protein receptors.
Wang Y; Yutuc E; Griffiths WJ
Br J Pharmacol; 2021 Aug; 178(16):3176-3193. PubMed ID: 32621622
[TBL] [Abstract][Full Text] [Related]
8. The 5,6-epoxycholesterol metabolic pathway in breast cancer: Emergence of new pharmacological targets.
de Medina P; Diallo K; Huc-Claustre E; Attia M; Soulès R; Silvente-Poirot S; Poirot M
Br J Pharmacol; 2021 Aug; 178(16):3248-3260. PubMed ID: 32696532
[TBL] [Abstract][Full Text] [Related]
9. 2-Hydroxypropyl-β-cyclodextrin reduces retinal cholesterol in wild-type and Cyp27a1
El-Darzi N; Mast N; Petrov AM; Pikuleva IA
Br J Pharmacol; 2021 Aug; 178(16):3220-3234. PubMed ID: 32698250
[TBL] [Abstract][Full Text] [Related]
10. Regulation of glycolytic genes in human macrophages by oxysterols: a potential role for liver X receptors.
Ménégaut L; Jalil A; Pilot T; van Dongen K; Crespy V; Steinmetz E; Pais de Barros JP; Geissler A; Le Goff W; Venteclef N; Lagrost L; Gautier T; Thomas C; Masson D
Br J Pharmacol; 2021 Aug; 178(16):3124-3139. PubMed ID: 33377180
[TBL] [Abstract][Full Text] [Related]
11. Shedding light on the roles of liver X receptors in cancer by using chemical probes.
Pontini L; Marinozzi M
Br J Pharmacol; 2021 Aug; 178(16):3261-3276. PubMed ID: 32673401
[TBL] [Abstract][Full Text] [Related]
12. Screening for liver X receptor modulators: Where are we and for what use?
Buñay J; Fouache A; Trousson A; de Joussineau C; Bouchareb E; Zhu Z; Kocer A; Morel L; Baron S; Lobaccaro JA
Br J Pharmacol; 2021 Aug; 178(16):3277-3293. PubMed ID: 33080050
[TBL] [Abstract][Full Text] [Related]
13. LDL receptors, caveolae and cholesterol in endothelial dysfunction: oxLDLs accomplices or victims?
Luchetti F; Crinelli R; Nasoni MG; Benedetti S; Palma F; Fraternale A; Iuliano L
Br J Pharmacol; 2021 Aug; 178(16):3104-3114. PubMed ID: 32986849
[TBL] [Abstract][Full Text] [Related]
14. The oxysterol receptor GPR183 in inflammatory bowel diseases.
Misselwitz B; Wyss A; Raselli T; Cerovic V; Sailer AW; Krupka N; Ruiz F; Pot C; Pabst O
Br J Pharmacol; 2021 Aug; 178(16):3140-3156. PubMed ID: 33145756
[TBL] [Abstract][Full Text] [Related]
15. Bone sarcomas in the immunotherapy era.
Heymann MF; Schiavone K; Heymann D
Br J Pharmacol; 2021 May; 178(9):1955-1972. PubMed ID: 31975481
[TBL] [Abstract][Full Text] [Related]
16. The ratio of ursodeoxycholyltaurine to 7-oxolithocholyltaurine serves as a biomarker of decreased 11β-hydroxysteroid dehydrogenase 1 activity in mouse.
Weingartner M; Stücheli S; Kratschmar DV; Birk J; Klusonova P; Chapman KE; Lavery GG; Odermatt A
Br J Pharmacol; 2021 Aug; 178(16):3309-3326. PubMed ID: 33450045
[TBL] [Abstract][Full Text] [Related]
17. Exploring mitochondrial cholesterol signalling for therapeutic intervention in neurological conditions.
Desai R; Campanella M
Br J Pharmacol; 2019 Nov; 176(22):4284-4292. PubMed ID: 31077345
[TBL] [Abstract][Full Text] [Related]
18. Early or deferred initiation of efavirenz during rifampicin-based TB therapy has no significant effect on CYP3A induction in TB-HIV infected patients.
Aklillu E; Zumla A; Habtewold A; Amogne W; Makonnen E; Yimer G; Burhenne J; Diczfalusy U
Br J Pharmacol; 2021 Aug; 178(16):3294-3308. PubMed ID: 33155675
[TBL] [Abstract][Full Text] [Related]
19. Cellular metabolism and diseases.
Maiuri MC; Maffia P
Br J Pharmacol; 2021 May; 178(10):2031-2033. PubMed ID: 33932230
[TBL] [Abstract][Full Text] [Related]
20. Short-chain fatty acids and bile acids in human faeces are associated with the intestinal cholesterol conversion status.
Matysik S; Krautbauer S; Liebisch G; Schött HF; Kjølbaek L; Astrup A; Blachier F; Beaumont M; Nieuwdorp M; Hartstra A; Rampelli S; Pagotto U; Iozzo P
Br J Pharmacol; 2021 Aug; 178(16):3342-3353. PubMed ID: 33751575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
